VANGUARD GROUP INC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,070,329,787
-10.4%
39,437,354
+1.5%
0.03%
-7.1%
Q2 2023$1,194,181,249
-12.6%
38,847,796
+2.4%
0.03%
-20.0%
Q1 2023$1,366,618,585
-2.9%
37,930,019
+6.5%
0.04%
-7.9%
Q4 2022$1,408,010,301
+0.3%
35,627,791
+1.9%
0.04%
-7.3%
Q3 2022$1,404,364,000
+1.7%
34,951,810
+6.4%
0.04%
+5.1%
Q2 2022$1,381,172,000
+11.3%
32,853,776
+3.1%
0.04%
+34.5%
Q1 2022$1,241,289,000
+5.1%
31,860,621
+7.5%
0.03%
+7.4%
Q4 2021$1,181,017,000
+8.8%
29,636,565
-1.3%
0.03%0.0%
Q3 2021$1,085,216,000
+8.8%
30,028,062
+23.4%
0.03%
+8.0%
Q2 2021$997,787,000
+1.6%
24,342,200
+8.1%
0.02%
-7.4%
Q1 2021$981,999,000
+966.9%
22,512,593
+1124.2%
0.03%
+800.0%
Q4 2020$92,041,000
+54.8%
1,838,966
+30.2%
0.00%
+50.0%
Q3 2020$59,440,000
-11.5%
1,412,886
+2.1%
0.00%0.0%
Q2 2020$67,162,0001,383,3600.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders